A new publication in EJC outlines EORTC’s strategy for the measurement of health-related quality of life and patient-reported outcomes in oncology.
The 6th EORTC Quality of Life in Cancer Clinical Trials Conference will take place on the 12th and 13th of May 2025, in Barcelona (Spain).
We reflect on how the UK and EU could grasp opportunities for scientific cooperation to promote health and wealth across the continent
The EORTC-2387 SPRINT study is the first pan-European Trial within Cohorts (TwiCs) targeting patients with oligometastatic disease.
Since 1962, EORTC has enrolled around 220,000 patients in clinical trials across tumour types.​ Many of these studies have changed best practice ​for treating
A new article by Pe, Voltz et al. in The Lancet Oncology summarises highlights from a joint EMA-EORTC workshop held on 29 February 2024
Navigating EU Clinical Trials: EORTC shares its experience in implementing new EU healthcare regulations that often have overlapping scopes but..
The EORTC offers a one-year research fellowship (renewable to a maximum of 3 years) to learn the methodology of cancer clinical studies and gain first experience working…
This year, Encontros da Primavera 2025 will host the course “How to Evolve from a Research Question to a Study Synopsis?”
